Evgeny Arons

Also affiliated with National Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Dabrafenib plus trametinib in patients with relapsed/refractoryBRAFV600E mutation–positive hairy cell leukemia”.

Dabrafenib plus trametinib in patients with relapsed/refractoryBRAFV600E mutation–positive hairy cell leukemia

Blood(2022)10.1182/blood.2021013658

N/A

1.1DataRank · unranked

42 citations

Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne‐Sophie Michallet +12 more

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

Blood Advances(2021)10.1182/bloodadvances.2021005039

N/A

0.937DataRank · unranked

28 citations

Evgeny Arons, Maryalice Stetler‐Stevenson, Constance M. Yuan, Hao‐Wei Wang, Hong Zhou +13 more

In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees

Leukemia(2020)10.1038/s41375-019-0702-7

N/A

0.464DataRank · unranked

7 citations

Anand Pathak, Samantha Jones, Ramita Dewan, Jessica Merberg, Sirisha Karra +17 more

Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia

Blood(2025)10.1182/blood.2025031243

N/A

0.163DataRank · unranked

1 citations

Constance M. Yuan, Hao‐Wei Wang, Chirayu Mohindroo, Hong Zhou, Mark Raffeld +8 more

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Nature Genetics(2022)10.1038/s41588-022-01113-z

N/A

0DataRank · unranked

140 citations

Megan L. Stanifer, Oscar Flórez-Vargas, Olusegun O. Onabajo, Brenen W. Papenberg, Muhammad Atif Zahoor +65 more

Characterization of B‐cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS‐CoV‐2 infection

Journal of Medical Virology(2023)10.1002/jmv.29179

N/A

0DataRank · unranked

0 citations

Kiersten Henry, Christopher Haas, M N Gould, Jack Tsintolas, Jack Mauter +5 more

Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy

JCO Precision Oncology(2025)10.1200/po-25-00269

N/A

0DataRank · unranked

2 citations

Brett Schroeder, Evgeny Arons, Constance M. Yuan, Hao‐Wei Wang, Mark Raffeld +15 more

Phase 1 trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox combined with rituximab for relapsed/refractory hairy cell leukemia.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7036

N/A

0DataRank · unranked

0 citations

Maryalice Stetler‐Stevenson, Constance M. Yuan, Hao‐Wei Wang, Hong Zhou, Mark Raffeld +10 more

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues

Blood Reviews(2021)10.1016/j.blre.2021.100888

N/A

0DataRank · unranked

11 citations

Evgeny Arons, Robert J. Kreitman

Genetic regulation of OAS1 nonsense-mediated decay underlies association with risk of severe COVID-19

medRxiv(2021)10.1101/2021.07.09.21260221

N/A

0DataRank · unranked

13 citations

Megan L. Stanifer, Oscar Flórez-Vargas, Olusegun O. Onabajo, Muhammad Atif Zahoor, Brenen W. Papenberg +49 more

Expression of the muscle-associated gene MYF6 in hairy cell leukemia

PLoS ONE(2020)10.1371/journal.pone.0227586

N/A

0DataRank · unranked

8 citations

Hong Zhou, Mark Sokolsky, Daniel Gorelik, Katherine Potocka, Sarah Davies +13 more